The Top 10 rare disease companies globally, ranked by worldwide orphan drug sales for 2018. Celgene takes top spot, followed by Roche and Novartis.
Made with Visme Infographic Maker
The Top 10 rare disease companies globally, ranked by worldwide orphan drug sales for 2018. Celgene takes top spot, followed by Roche and Novartis.
Made with Visme Infographic Maker
The world’s bestselling treatments for 2019 by sales in USD billions. AbbVie’s Humira is out in front…
Following the recent news of Remegen’s massive USD 515 million IPO in November 2020, we bring you the seven…
Vaccines are back on top of the pharma priority list as companies race against the clock to develop the first…
A new report from specialist pharma and biotech consultancy Novasecta explores how the world’s top 100 pharma…
Novartis takes the top spot for the third consecutive year, while Takeda reports the highest growth.
The top ten global generics and biosimilars companies according to a recent Informa Pharma Intelligence ranking for…